Akeso

This study tested whether adding the drug AK104 to standard chemotherapy helps people with advanced stomach or gastroesophageal junction cancer live longer. It involved 610 adults who had not received prior treatment. The goal was to see if the combination improves survival and s…

This study tested a new medicine called AK111 for people with active ankylosing spondylitis, a condition that causes back pain and stiffness. 510 adults who did not get enough relief from standard painkillers took part. The goal was to see if AK111 could reduce pain and improve m…

This study tested a combination of two experimental drugs (AK112 and AK117) with or without chemotherapy in 154 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can shrink tumors. The drugs work …

This study tested a new drug called AK112 in 40 people with advanced liver cancer that could not be removed by surgery. The drug targets two proteins (PD-1 and VEGF) to help the immune system fight the cancer and cut off its blood supply. The main goals were to see if the drug is…

This trial tested a new drug called AK112 in 108 people with advanced non-small cell lung cancer (stage IIIB/C or IV) whose tumors had a PD-L1 score of 1% or higher. The drug is a bispecific antibody that targets both PD-1 and VEGF to help the immune system fight cancer and block…

This study tested a new drug called AK120 in 450 adults with moderate to severe atopic dermatitis (eczema). The goal was to see if the drug is safe and helps improve skin symptoms like redness and itching. Researchers measured side effects and changes in eczema severity over time…